Tandem Diabetes Care Is Maintained at Buy by Truist Securities
Ratings actions from Benzinga: GMT) Tandem Diabetes Care Price Target Cut to $28.00/Share From $31.00 by Truist SecuritiesRatings actions from Benzinga
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.